Details
Submit your completed abstract through the correct portal link. Please do not include symbols, tables, pictures or diagrams within the content of your abstract to avoid formatting errors.
You will receive a confirmation email acknowledging receipt of your submission.
The ACTA 2025 Clinical Trials Portal and the Clinical Registries Symposium and Workshop Portal will close on Friday 1 August at 5pm AEST. Submissions received after this time will not be accepted.
Preparation
Length - Maximum 300 words (excluding references)
Title - Limited to 20 words in sentence case (i.e. capital letters are used for the first letter of the first work and proper nouns; all other words are lower case.
Author / Co-Authors - Include all authors. The first author will be presumed to be the presenting author unless otherwise specified at abstract submission.
Required abstract structure - Organise the abstract as follows:
- Aim (State concisely why the study was conducted)
- Method (Indicate the locale, sample number, principal test(s) performed, and the types of statistical analysis employed)
- Results (Confirm or refute the hypothesis, supported by statistics if appropriate)
- Conclusion (State the effect of the study on future patient management or the understanding of basic processes)
- References (Include up to 3 references if applicable)
Guidelines
ACTA Members: Oral presentations are usually 15 minutes, or as appropriate for the program.
Posters: Poster presentations will be accepted at this years conference.
Audio Visual: Each meeting room will be equipped for the presentation of PowerPoint slides and include a data projector, lectern and microphone.
Multimedia clips should be embedded in your slides. Other audio-visual aids, such as overhead projectors, are not available.
All presentations must be digital in either PowerPoint or Keynote. Speakers will be required to bring their presentations on a USB stick with them to the conference.
Presentations: Must be given to the conference organiser at least 1 week prior to the start of the Symposium. It is not good practice changing laptop connections at the lectern so presenting on your own laptop is not permitted.
Submissions: All abstracts are to be submitted through the submission portals. Please do not include symbols, tables, pictures or diagrams within the ‘content’ of your abstract to avoid formatting errors.
Submissions sent via email will not be accepted.
Selection and Notification: The ACTA 2025 Clinical Trials and Registries Symposium Convener serves as the head of the Steering Committee and will make the final decision on which abstracts are accepted.
Abstracts will be reviewed against the following criteria:
- Completed rather than future work (i.e. final results)
- Original data of high quality
- An analysis that extends existing knowledge
- Diversity and consumer involvement
- Clarity of methodology, analysis and presentation of results- specific, rather than general findings
Results of the abstract review will be sent to the contact author by Monday 8 September.
Presenting authors will be notified after the closing date regarding the status of their abstract. All presenters will be required to register for the conference and pay the appropriate registration fees should they be selected.
All presenters need to meet their own travel and accommodation costs.
* Please note, all successful delegates presenting abstracts are required to register under the relevant registration category for the event. A 15% discount code will be provided upon acceptance of your abstract which will allow you to register at the discounted rate.
Australian Clinical Trials Alliance
© Copyright 2025 | ACTA | All Rights Reserved